바이오해킹 시장 기회, 성장 촉진요인, 산업 동향 분석 및 예측(2025-2034년)

The Global Biohacking Market was valued at USD 24.5 billion in 2024 and is estimated to grow at a CAGR of 16.5% to reach USD 111.3 billion by 2034. Biohacking is emerging as a transformative trend at the intersection of science, technology, and self-improvement. It offers individuals the tools to take control of their physical and mental well-being through personalized interventions. From nutrition and sleep optimization to genetic engineering and implantable devices, the spectrum of biohacking is broad and constantly evolving. What's fueling this movement is the growing consumer shift toward preventive healthcare and performance optimization.

People are no longer waiting for symptoms to act-they're using real-time data and advanced health tools to preempt issues and enhance quality of life. As healthcare becomes more individualized, demand is rising for innovative solutions that allow users to monitor, analyze, and fine-tune their biological functions on their own terms. The rise in chronic illnesses, increasing healthcare costs, and growing access to affordable wearable tech are accelerating the adoption of biohacking practices worldwide. This trend is further amplified by social media, online health communities, and DIY biology groups that encourage experimentation and knowledge sharing.

The wearable technology segment generated USD 7 billion in 2024 and is projected to grow at a CAGR of 16.8% through 2034. Users are increasingly turning to smartwatches, fitness bands, and smart rings to track vital metrics like sleep cycles, heart rate, brain activity, and daily performance levels. These devices offer personalized insights in real-time, helping users identify trends, make informed decisions, and tweak their daily routines for better health outcomes. By providing continuous tracking and actionable feedback, wearable tech is becoming an essential tool for individuals looking to upgrade their health and wellness journeys. The ability to detect early changes in physiological or cognitive states gives users the power to intervene early, adjust habits, and stay ahead of potential health concerns.

In terms of application, the diagnosis and treatment segment generated USD 7 billion and held a 28.4% market share in 2024. The growing global burden of chronic conditions like diabetes and cardiovascular disease is pushing users to seek more control over their health. Through advanced sensors and home-based monitoring tools, biohackers can track glucose levels, hormone fluctuations, blood pressure, and more. This real-time data access supports early detection, encourages preventative care, and reduces dependency on traditional healthcare visits. It empowers users to make behavior and lifestyle changes based on precise health data, significantly lowering long-term health risks.

The United States Biohacking Market generated USD 7.9 billion in 2023. The country's high incidence of chronic conditions continues to drive demand for advanced biohacking tools. Cutting-edge research from healthcare institutions, biotech firms, and startups fuels innovation across the space. Companies are increasingly focused on disease prevention, personalized health solutions, and next-gen technology development.

Some of the prominent players in the Global Biohacking Industry include Neuralink, Oura Health Oy, WHOOP, Cyborg Nest, Muse, Cronometer, OpenBCI, Senseonics, Synbiota, Thync Global, Viome Life Science, Fitbit, TrackMyStack, Nuanic, OsteoStrong, and Proteus Digital Health. To stay competitive, these companies are heavily investing in research and development, launching next-gen wearable devices, expanding their product lines, and integrating AI-driven health platforms. Strategic partnerships, market expansion, and digital innovation remain key to engaging consumers and elevating brand value in this fast-growing space.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of chronic diseases
    • 3.2.1.2 Technological advancements in biohacking
    • 3.2.1.3 Growing demand for wearable devices
    • 3.2.1.4 Increasing health awareness
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High costs of advanced devices
    • 3.2.2.2 Lack of skilled professionals
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter’s analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Wearable
  • 5.2.1 Wearable neurotech
  • 5.2.2 Oura ring
  • 5.2.3 Muse headband
  • 5.2.4 Other wearables
• 5.3 Implants
  • 5.3.1 Blood test implant
  • 5.3.2 Circadia implant
  • 5.3.3 Cardiac and vascular implants
  • 5.3.4 Other implants
• 5.4 Gene modification kits
• 5.5 Smart drugs
• 5.6 Supplements
• 5.7 Mobile apps
• 5.8 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Synthetic biology
• 6.3 Genetic engineering
• 6.4 Forensic science
• 6.5 Diagnosis and treatment
• 6.6 Drug testing
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals and clinics
• 7.3 Pharmaceutical and biotechnology companies
• 7.4 Forensic laboratories
• 7.5 Academic and research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Cyborg Nest
• 9.2 Cronometer
• 9.3 Fitbit
• 9.4 Muse
• 9.5 Nuanic
• 9.6 Neuralink
• 9.7 OpenBCI
• 9.8 OsteoStrong
• 9.9 Oura Health Oy
• 9.10 Proteus Digital Health
• 9.11 TrackMyStack
• 9.12 Thync Global
• 9.13 Synbiota
• 9.14 Senseonics
• 9.15 Viome Life Science
• 9.16 WHOOP